JMAC Enterprises’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
JMAC Enterprises's PFE Position: Q2 2026 in Review
JMAC Enterprises increased its Pfizer (PFE) stake by 0.02% in Q2 2026, buying an estimated $157 and bringing the position to 27,652 shares worth $666K. The position accounts for 0.11% of the portfolio, ranked #83.
JMAC Enterprises first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.47M in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- JMAC Enterprises held 27,652 shares of Pfizer worth $666K as of Q2 2026.
- JMAC Enterprises bought 6 Pfizer shares in Q2 2026, an estimated $157.
- Pfizer made up 0.11% of JMAC Enterprises's portfolio in Q2 2026, its #83 holding.
- JMAC Enterprises first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- JMAC Enterprises's Pfizer position peaked at $2.47M in Q1 2023.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.